- $227.02m
- $80.80m
- 46
- 12
- 53
- 31
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 34.1 | 27.8 | 81.9 | 41.7 | 50.4 |
Operating Profit | -34.1 | -27.8 | -81.9 | -41.7 | -50.4 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -34.7 | -29.5 | -82.2 | -39.2 | -42.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -34.7 | -29.5 | -82.2 | -39.2 | -42.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -34.7 | -29.5 | -82.2 | -39.2 | -42.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -34.7 | -29.5 | -82.2 | -39.2 | -42.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.666 | -0.953 | -1.31 | -0.374 | -0.335 |
Dividends per Share |